02/27
Headlines

CYTR

Healthcare Losers: CytRx (NASDAQ:CYTR), Trivascular Technologies (NASDAQ:TRIV), Neuralstem (NYSEMKT:CUR), Ventrus Biosciences Inc (NASDAQ:VTUS)

Kristen Barton03 mins

The company on May 28 announced updated results from its ongoing multicenter, randomized, open-label global Phase 2b clinical trial investigating the efficacy and safety of aldoxorubicin compared with doxorubicin as first-line therapy in subjects with metastatic, locally advanced or unresectable soft tissue sarcomas (STS). CytRx Corporation (NASDAQ:CYTR) stock performance was -5.41% in last session and…

Read More

Top Losers: StemCells (NASDAQ:STEM), CytRx (NASDAQ:CYTR), Neonode (NASDAQ:NEON), Halcon Resources (NYSE:HK), Yamana Gold (NYSE:AUY)

Jayne Crisman03 mins

Research analysts at Maxim Group lifted their price target on shares of Stemcells Inc (NASDAQ:STEM) from $2.50 to $5.00 in a report released on Friday. The firm currently has a “buy” rating on the stock. Maxim Group’s price objective indicates a potential upside of 155.10% from the company’s current price. StemCells Inc (NASDAQ:STEM) stock performance…

Read More

Biotech Volatile Movements: CEL-SCI (NYSEMKT:CVM), NewLink Genetics (NASDAQ:NLNK), Alder Biopharmaceuticals (NASDAQ:ALDR), CytRx (NASDAQ:CYTR), StemCells Inc (NASDAQ:STEM)

Kevin Long03 mins

CEL-SCI Corporation (NYSEMKT:CVM) announced that Geert Kersten Chief Executive Officer will be presenting at the 2014 BIO International Convention on Wednesday June 25th at 2:00 p.m. PDT. Hosted by the Biotechnology Industry Organization (BIO) this year’s global event for biotechnology will take place June 23-26 at the San Diego Convention Center in San Diego California….

Read More
Gilead Sciences GILD NASDAQ:GILD

Biotech Volatile Stocks: DARA Biosciences Inc (NASDAQ:DARA), Concert Pharmaceuticals Inc (NASDAQ:CNCE), Prosensa Holding NV (NASDAQ:RNA), CytRx Corporation (NASDAQ:CYTR)

Kevin Long02 mins

DARA Biosciences Inc (NASDAQ:DARA) on May 15 announced its support for Neuropathy Awareness Week which is being observed during the week of May 12, 2014 and sponsored in the U.S. by The Neuropathy Association (www.neuropathy.org). DARA Biosciences Inc (NASDAQ:DARA) stock performance was -26.61% in last session and finished the day at $1.60. Traded volume was…

Read More

Notable Movers: ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS), PTC Therapeutics, Inc. (NASDAQ:PTCT), Orexigen Therapeutics, Inc. (NASDAQ:OREX), CytRx Corporation (NASDAQ:CYTR), ZIOPHARM Oncology (NASDAQ:ZIOP)

Kristen Barton03 mins

ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) presented results from a global, multi-center, open-label, comparator-controlled phase II study in patients undergoing total knee replacement surgery or total knee arthroplasty (TKA). Two doses of ISIS-FXIRx (200mg, 300mg) were compared to Sanofi’s Lovenox (enoxaparin). ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) stock performance was 11.26% in last session and finished the day at…

Read More

Micro-cap Active runners: CytRx Corporation (NASDAQ:CYTR), Response Genetics (NASDAQ:RGDX), Catalyst Pharmaceutical Partners (NASDAQ:CPRX), Rexahn Pharmaceuticals (NYSEMKT:RNN)

Mark DeFrance02 mins

CytRx Corporation (NASDAQ:CYTR) seeks to present the detailed results of the positive outcome from the study which was conducted in an animal representation of glioblastoma at the AACRAM which will be held from between April 5 and April 9 in San Diego, CA. CytRx Corporation (NASDAQ:CYTR) stock performance was 3.67% in last session and finished…

Read More